Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Leyden

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
BMJ Open Gastroenterology|January 31, 2018
Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)Juliette Sheridan, Carol Ann Coe, Peter Doran, et al.
Journal of Crohn'S & Colitis|January 9, 2026
Quality metrics reflecting patient experience of GI endoscopy in Inflammatory Bowel Disease: results of national endoscopy dataset analysisFiona Jones, Aonghus Lavelle, Finbar McCarthy, et al.
Cancer Epidemiology|August 8, 2017
High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomesMargaret Walshe, Robert Moran, Marie Boyle, et al.
Nature Medicine|April 13, 2010
Multispectral scanning during endoscopy guides biopsy of dysplasia in Barrett's esophagusLe Qiu, Douglas K Pleskow, Ram Chuttani, et al.
European Journal of Gastroenterology & Hepatology|June 8, 2018
Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitisJim O'Connell, Cathy Rowan, Roisin Stack, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 22, 2024
Effectiveness, safety, and cost of combination advanced therapies in inflammatory bowel diseaseCathy McShane, Rachel Varley, Anne Fennessy, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 21, 2020
Barrett's Registry Collaboration of academic centers in Ireland reveals high progression rate of low-grade dysplasia and low risk from nondysplastic Barrett's esophagus: report of the RIBBON networkLisa M O'Byrne, Jolene Witherspoon, Roy J J Verhage, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
BMJ Open Gastroenterology|January 31, 2018
Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)Juliette Sheridan, Carol Ann Coe, Peter Doran, et al.
Journal of Crohn'S & Colitis|January 9, 2026
Quality metrics reflecting patient experience of GI endoscopy in Inflammatory Bowel Disease: results of national endoscopy dataset analysisFiona Jones, Aonghus Lavelle, Finbar McCarthy, et al.
Cancer Epidemiology|August 8, 2017
High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomesMargaret Walshe, Robert Moran, Marie Boyle, et al.
Nature Medicine|April 13, 2010
Multispectral scanning during endoscopy guides biopsy of dysplasia in Barrett's esophagusLe Qiu, Douglas K Pleskow, Ram Chuttani, et al.
European Journal of Gastroenterology & Hepatology|June 8, 2018
Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitisJim O'Connell, Cathy Rowan, Roisin Stack, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 22, 2024
Effectiveness, safety, and cost of combination advanced therapies in inflammatory bowel diseaseCathy McShane, Rachel Varley, Anne Fennessy, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 21, 2020
Barrett's Registry Collaboration of academic centers in Ireland reveals high progression rate of low-grade dysplasia and low risk from nondysplastic Barrett's esophagus: report of the RIBBON networkLisa M O'Byrne, Jolene Witherspoon, Roy J J Verhage, et al.
Pageof 2